EN
ES

Fertility Researchers

OUR INVESTIGATORS

Alfonso Bermejo, M.D., Ph.D.

MINIFIV Clinical Director

MINIFIV Madrid

Contact info:

Biography

Dr. Alfonso Bermejo, MD, is an attending physician at MINIFIV CLINIC Madrid, Spain, where he serves as the Clinical Director. He obtained his Medical degree from the University of Alcalá in 2005, and completed his residency training in Obstetrics and Gynecology at the La Paz Hospital in Madrid. In addition, Dr. Bermejo obtained his PhD at the Medicine and Surgery Department of the University of Rey Juan Carlos School of Health Sciences in 2013, and completed his Reproductive Endocrinology and Infertility fellowship training at IVI Madrid Clinic.

Dr. Bermejo has been involved in teaching since his early career, participating as lecturer for medical students of Rey Juan Carlos University.
Dr. Bermejo has been invited to speak nationally and internationally and has authored and co-authored many peer reviewed publications, and published book chapters. He serves as Ad Hoc Reviewer for Reproductive BioMedicine Online, Human Reproduction, and Reproductive Biology and Endocrinology. His research interests include minimal stimulation and natural IVF cycles and endometrial receptivity.

See more

Education and Training

BS	Claret Scholl (1999)
MD	University of Alcalá (2005)
Ph.D. (Medicine)	Rey Juan Carlos University (2013)
Residency	La Paz Hospital (2010)
Fellowship	IVI Madrid Clinic (2013)

Publications

Protocolo de ciclo natural para tratamientos de fiv: Resultados clínicos
Iglesias J P, Bermejo A, Carreño I, Castro B, Seco L, Vazquez R,

Medicina Reproductiva y Embriología Clínica. 2017 doi: 10.1016/j.medre.2017.06.003

The impact of using the combined oral contraceptive pill for cycle scheduling on gene expression related to endometrial receptivity
Bermejo A, Iglesias C, Ruiz-Alonso M, Blesa D, Simon C, Pellicer A, Garcia-Velasco J A,

Hum Reprod. Jun. 2014 doi: 10.1093/humrep/deu065

Mild ovarian stimulation using clomiphene citrate and menotropins versus clomiphene citrate and recombinant follicle-stimulating hormone/luteinizing hormone combination in low responder patients
Bermejo A, Ruiz F, Martinez-Salazar J, Mayoral M, Garcia-Velasco J A,

IVF Lite. 2014 doi:

The impact of using the combined oralcontraceptive pill for cycle scheduling ongene expression related to endometrial receptivity.
Bermejo A, Iglesias C, Ruiz-Alonso M, Blesa D, Simon C, Pellicer A, Garcia-Velasco J A,

J Hum Reprod. 2014 doi:

Cycle scheduling for in vitro fertilization with oral contraceptive pills versus oral estradiol valerate: a randomized, controlled trial.
Hauzman EE, Zapata A, Bermejo A, Iglesias C, Pellicer A, Garcia-Velasco J A,

Reprod Biol Endocrinol. 2013 doi:

Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression
Bermejo A, Cerrillo M, Ruiz M, Blesa D, Simon C, Pellicer A, Garcia-Velasco J A,

Fertil Steril. 2013 doi:

In vitro fertilization outcome in women with unoperated bilateral endometriomas
Benaglia L, Bermejo A, Somigliana E, Faulisi S, Ragni G, Fedele L, Garcia-Velasco J A,

Fertil Steril. 2013 doi:

Pregnancy outcome in women with endometriomas achieving pregnancy through IVF
Benaglia L, Bermejo A, Somigliana E, Scarduelli C, Ragni G, Fedele L, Garcia-Velasco J A,

Hum Reprod. Jun. 2012 doi: 10.1093/humrep/des054

Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial
Garcia-Velasco J A, Bermejo A, Ruiz F, Martinez-Salazar J, Requena A, Pellicer A,

Fertil Steril. Sep. 2011 doi: 10.1016/j.fertnstert.2011.06.022

Síndrome microcefalia-coriorretinopatía-linfedema.
Novelle M, Bermejo A, Herrero B, Rodriguez R, Gonzalez A,

Prog Obstet Ginecol. 2011 doi: